Genetic correlates of proliferative vitreoretinopathy

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 3, 2013, Pages 1679-

  Stryjewski, Tomasz P ^a   Vavvas, Demetrios G ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PIK3CG PROTEIN, HUMAN; SMAD7 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; FIBROSIS; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; PREDICTION; PRIORITY JOURNAL; RETINA DETACHMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VITREORETINOPATHY; EUROPE; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; MALE; METHODOLOGY;

CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; EUROPE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RESEARCH DESIGN; RETINAL DETACHMENT; SMAD7 PROTEIN; TUMOR NECROSIS FACTOR-ALPHA; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84875441484     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11508     Document Type: Article

References (2)

1. Girard P, Mimoun G, Karpouzas I, Montefiore G. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina. 1994;14:417-424.
2. Rojas J, Fernandez I, Pastor JC, et al. A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2013;54:1665-1678.